Clinical Trial Update: Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating the efficacy and safety of an interleukin-6 receptor inhibitor combined with endovascular therapy for acute posterior circulation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Interleukin-6 receptor inhibitor

Snippet

Sponsor: Capital Medical University | Conditions: Ischemic Stroke | Phase 3 | Status: RECRUITING